Lodestar Investment Counsel Has Lowered Its Omnicom Group (OMC) Stake; Last Week Verona Pharma plc (LON:VRP) Analysts

Among 2 analysts covering Verona Pharma PLC (LON:VRP), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Verona Pharma PLC had 23 analyst reports since September 18, 2015 according to SRatingsIntel. The stock has “Buy” rating by N+1 Singer on Tuesday, November 7. The company was maintained on Thursday, January 28 by N+1 Singer. N+1 Singer maintained the stock with “Corporate” rating in Tuesday, June 27 report. N+1 Singer maintained Verona Pharma plc (LON:VRP) on Monday, February 27 with “Corporate” rating. On Wednesday, March 22 the stock rating was maintained by N+1 Singer with “Corporate”. As per Friday, March 2, the company rating was maintained by N+1 Singer. As per Monday, September 26, the company rating was maintained by N+1 Singer. The firm earned “Corporate” rating on Tuesday, September 29 by N+1 Singer. On Wednesday, April 19 the stock rating was maintained by N+1 Singer with “Corporate”. On Wednesday, January 18 the stock rating was maintained by N+1 Singer with “Corporate”. See Verona Pharma plc (LON:VRP) latest ratings:

02/03/2018 Broker: N+1 Singer Rating: Strong Buy Maintain
27/11/2017 Broker: N+1 Singer Rating: Buy New Target: GBX 327.00 Maintain
08/11/2017 Broker: Jefferies Rating: Buy Old Target: GBX 250.00 New Target: GBX 250.00 Maintain
07/11/2017 Broker: N+1 Singer Rating: Buy Maintain

Lodestar Investment Counsel Llc decreased Omnicom Group Inc. (OMC) stake by 55.53% reported in 2017Q3 SEC filing. Lodestar Investment Counsel Llc sold 101,633 shares as Omnicom Group Inc. (OMC)’s stock declined 2.32%. The Lodestar Investment Counsel Llc holds 81,389 shares with $6.03 million value, down from 183,022 last quarter. Omnicom Group Inc. now has $16.98B valuation. The stock increased 0.37% or $0.27 during the last trading session, reaching $73.72. About 1.83M shares traded. Omnicom Group Inc. (NYSE:OMC) has risen 1.15% since March 14, 2017 and is uptrending. It has underperformed by 15.55% the S&P500.

Lodestar Investment Counsel Llc increased Alphabet Inc Cl C stake by 519 shares to 19,370 valued at $18.58M in 2017Q3. It also upped Starwood Property Trust (NYSE:STWD) stake by 15,275 shares and now owns 242,825 shares. Omega Healthcare Investors In (NYSE:OHI) was raised too.

Analysts await Omnicom Group Inc. (NYSE:OMC) to report earnings on April, 17. They expect $1.05 EPS, up 8.25% or $0.08 from last year’s $0.97 per share. OMC’s profit will be $241.78 million for 17.55 P/E if the $1.05 EPS becomes a reality. After $1.55 actual EPS reported by Omnicom Group Inc. for the previous quarter, Wall Street now forecasts -32.26% negative EPS growth.

Investors sentiment decreased to 0.96 in Q3 2017. Its down 0.04, from 1 in 2017Q2. It worsened, as 56 investors sold OMC shares while 213 reduced holdings. 65 funds opened positions while 203 raised stakes. 230.60 million shares or 2.33% more from 225.35 million shares in 2017Q2 were reported. Trillium Asset Mngmt Lc invested in 0.6% or 142,685 shares. Robeco Institutional Asset Management Bv has invested 0.05% in Omnicom Group Inc. (NYSE:OMC). Ibm Retirement Fund reported 5,663 shares. Commonwealth Equity Svcs has 0% invested in Omnicom Group Inc. (NYSE:OMC). 4,559 are held by Atria Invests Limited Liability. Alpha Windward Ltd Liability Corporation has invested 0.3% in Omnicom Group Inc. (NYSE:OMC). Pinebridge Invests Lp owns 266,744 shares. Cadence Cap Management Limited Liability Corporation owns 66,874 shares or 0.31% of their US portfolio. Gotham Asset Mgmt Llc owns 448,180 shares or 0.49% of their US portfolio. New Jersey-based Prudential Financial Incorporated has invested 0.06% in Omnicom Group Inc. (NYSE:OMC). Twin Cap holds 0.21% or 53,650 shares. Fny Managed Accounts Limited Com has invested 0.02% in Omnicom Group Inc. (NYSE:OMC). The Maryland-based Proshare Advsrs Limited Com has invested 0.04% in Omnicom Group Inc. (NYSE:OMC). Whittier Trust Company has invested 0% of its portfolio in Omnicom Group Inc. (NYSE:OMC). Geode Cap Mgmt Ltd Liability Corporation invested 0.07% in Omnicom Group Inc. (NYSE:OMC).

Among 16 analysts covering Omnicom (NYSE:OMC), 4 have Buy rating, 1 Sell and 11 Hold. Therefore 25% are positive. Omnicom has $101 highest and $69 lowest target. $83.43’s average target is 13.17% above currents $73.72 stock price. Omnicom had 49 analyst reports since July 23, 2015 according to SRatingsIntel. The company was upgraded on Friday, February 16 by BMO Capital Markets. Credit Suisse maintained Omnicom Group Inc. (NYSE:OMC) on Friday, July 14 with “Neutral” rating. The company was maintained on Monday, September 11 by BMO Capital Markets. The stock of Omnicom Group Inc. (NYSE:OMC) has “Hold” rating given on Thursday, July 13 by BMO Capital Markets. The company was maintained on Monday, March 21 by JP Morgan. The rating was maintained by RBC Capital Markets on Monday, September 25 with “Buy”. On Monday, September 18 the stock rating was maintained by Jefferies with “Hold”. On Monday, October 17 the stock rating was maintained by Pivotal Research with “Hold”. BMO Capital Markets maintained Omnicom Group Inc. (NYSE:OMC) rating on Wednesday, November 22. BMO Capital Markets has “Hold” rating and $85.0 target. The firm earned “Neutral” rating on Wednesday, October 18 by Credit Suisse.

Since October 19, 2017, it had 0 buys, and 4 sales for $847,042 activity. RICE LINDA JOHNSON sold $36,342 worth of stock. Sherman Peter K. had sold 8,310 shares worth $617,516 on Monday, December 11. 2,000 shares were sold by Hewitt Dennis E., worth $154,758 on Wednesday, February 21.

The stock decreased 2.57% or GBX 3.85 during the last trading session, reaching GBX 146.15. About 2,732 shares traded. Verona Pharma plc (LON:VRP) has 0.00% since March 14, 2017 and is . It has underperformed by 16.70% the S&P500.

Free Email Newsletter

Enter your email address below to get the latest news and analysts’ ratings for your stocks with our free daily email newsletter: